Healthpeak Properties financials
$20.13+0.15%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $749.8M | $738.8M | $657.6M | $705.9M | $678.5M | $687.1M | $653.2M | $700.4M | $687.7M | $600.8M |
| Gross profit | $416.7M | $738.8M | $1.50B | $414.0M | $402.4M | $687.1M | $1.45B | $420.1M | $413.8M | $357.1M |
| Gross margin | 55.6% | 100.0% | 227.9% | 58.6% | 59.3% | 100.0% | 222.1% | 60.0% | 60.2% | 59.4% |
| Operating income | $101.6M | $78.7M | $77.5M | $129.4M | $105.5M | $117.3M | $55.6M | $109.3M | $96.4M | $7.3M |
| Net income | $52.7M | $193.5M | $114.0M | -$117.1M | $31.6M | $42.4M | $4.5M | $85.9M | $145.8M | $6.5M |
| Net margin | 7.0% | 26.2% | 17.3% | −16.6% | 4.7% | 6.2% | 0.7% | 12.3% | 21.2% | 1.1% |
| Diluted EPS | $0.08 | $0.28 | $0.16 | $-0.17 | $0.05 | $0.06 | $0.01 | $0.12 | $0.21 | $0.01 |
| EBITDA | $381.3M | $390.3M | $446.4M | $293.8M | $361.3M | $387.8M | $441.2M | $308.0M | $387.1M | $333.8M |
| Operating cash flow | $361.1M | $260.9M | $294.1M | $315.0M | $363.5M | $279.4M | $283.5M | $318.2M | $316.2M | $152.6M |
| Free cash flow | $89.6M | -$309.1M | -$365.3M | $85.9M | $205.2M | $75.9M | $83.1M | $143.9M | $193.7M | $45.5M |
| Diluted shares | 689.9M | 695.2M | 694.9M | 694.9M | 695.2M | 699.1M | 700.3M | 700.1M | 703.3M | 601.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.63B | $1.17B | $467.5M | $91.0M | $89.4M | $70.6M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $10.03B | $10.42B | $9.85B | $9.13B | $9.04B | $8.88B |
| Total assets | $21.68B | $21.62B | $20.34B | $19.58B | $19.81B | $19.82B |
| Total liabilities | $12.18B | $12.56B | $12.03B | $11.32B | $11.22B | $10.97B |
| Shareholders' equity | $9.12B | $8.68B | $7.80B | $7.89B | $8.23B | $8.49B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology